These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8806654)

  • 1. Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence.
    Pramono ZA; Takeshima Y; Alimsardjono H; Ishii A; Takeda S; Matsuo M
    Biochem Biophys Res Commun; 1996 Sep; 226(2):445-9. PubMed ID: 8806654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries.
    Adams AM; Harding PL; Iversen PL; Coleman C; Fletcher S; Wilton SD
    BMC Mol Biol; 2007 Jul; 8():57. PubMed ID: 17601349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
    Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R
    Neuromuscul Disord; 1999 Jul; 9(5):330-8. PubMed ID: 10407856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of antisense oligonucleotide length on dystrophin exon skipping.
    Harding PL; Fall AM; Honeyman K; Fletcher S; Wilton SD
    Mol Ther; 2007 Jan; 15(1):157-66. PubMed ID: 17164787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
    Errington SJ; Mann CJ; Fletcher S; Wilton SD
    J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
    Takeshima Y; Yagi M; Wada H; Matsuo M
    Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric RNA and 2'-O, 4'-C-ethylene-bridged nucleic acids have stronger activity than phosphorothioate oligodeoxynucleotides in induction of exon 19 skipping in dystrophin mRNA.
    Yagi M; Takeshima Y; Surono A; Takagi M; Koizumi M; Matsuo M
    Oligonucleotides; 2004; 14(1):33-40. PubMed ID: 15104894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript.
    Wilton SD; Fall AM; Harding PL; McClorey G; Coleman C; Fletcher S
    Mol Ther; 2007 Jul; 15(7):1288-96. PubMed ID: 17285139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing.
    Takeshima Y; Yagi M; Matsuo M
    Methods Mol Biol; 2012; 867():131-41. PubMed ID: 22454059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
    Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
    BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
    Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
    Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon.
    Surono A; Van Khanh T; Takeshima Y; Wada H; Yagi M; Takagi M; Koizumi M; Matsuo M
    Hum Gene Ther; 2004 Aug; 15(8):749-57. PubMed ID: 15319032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
    van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
    Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
    McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
    Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.
    Gebski BL; Mann CJ; Fletcher S; Wilton SD
    Hum Mol Genet; 2003 Aug; 12(15):1801-11. PubMed ID: 12874101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy.
    Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A
    Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.
    Arechavala-Gomeza V; Graham IR; Popplewell LJ; Adams AM; Aartsma-Rus A; Kinali M; Morgan JE; van Deutekom JC; Wilton SD; Dickson G; Muntoni F
    Hum Gene Ther; 2007 Sep; 18(9):798-810. PubMed ID: 17767400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.
    Echigoya Y; Yokota T
    Nucleic Acid Ther; 2014 Feb; 24(1):57-68. PubMed ID: 24380394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.
    Shiga N; Takeshima Y; Sakamoto H; Inoue K; Yokota Y; Yokoyama M; Matsuo M
    J Clin Invest; 1997 Nov; 100(9):2204-10. PubMed ID: 9410897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.